Meeting to be held in Chicago on January 23 and in the Midwest on January 24 hosted by Piper Sandler.Invest with Confidence: Follow TipRanks' ...

Phreesia (PHR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...

Analyst predicts Phreesia's revenue per client will accelerate, as company shifts focus to monetizing existing clients. Upgraded rating and PT raised.

RBC Capital analyst Sean Dodge upgraded Phreesia (PHR) to Outperform from Sector Perform with a price target of $32, up from $24. The firm ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $31.0, a high estimate of $34.00, and a low estimate of $29.00. This upward trend is apparent, ...

Phreesia (PHR) closed the last trading session at $23.84, gaining 25.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...

January 17, 2025, 04:12 am ET, BY Momei- Contributor, Stock Traders Daily| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) ...

Chicago, IL – January 24, 2025 – Today, Zacks Equity Research Equity are Enovis ENOV, Omnicell OMCL and Phreesia PHR. Link: ...

Phreesia, Inc. (NYSE:PHR – Get Free Report) has earned a consensus rating of “Buy” from the twelve brokerages that are covering the company, MarketBeat.com reports. Twelve analysts have rated the ...

Phreesia (NYSE:PHR – Free Report) had its price objective raised by Citigroup from $31.00 to $35.00 in a research note issued to investors on Friday morning,Benzinga reports. They currently have a buy ...

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation ...